Finance ❯Mergers and Acquisitions

Valuation

Market Trends Cash Deals Sports Teams Alaska Airlines Market Growth Share Prices

Eli Lilly to Acquire Verve Therapeutics in $1.3 Billion Gene-Editing Deal

This acquisition secures Lilly’s full rights to a Fast Track–designated cardiovascular gene-editing therapy.

Sanofi to Acquire Blueprint Medicines for $9.1 Billion, Boosting Its Rare Immunology Pipeline

Hailey Bieber Sells Rhode to e.l.f. Beauty for Up to $1 Billion

Paul Marshall Buys The Spectator for £100 Million